A recent study demonstrated that the tumor-secreted factor signal peptide, cubulin domain, epidermal-growth-factor-like protein 2 (SCUBE2), regulated by the ER signaling pathway, mediates bone metastasis in luminal-type breast cancer through immune suppression [28]. Here, SCUBE2 is linked to breast cancer.